European stocks jumped to a record high on Wednesday powered by heavyweight technology and healthcare stocks, with markets ...

There is a 'valley of death' in European research and innovation, says CEO of Novo Nordisk Foundation ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novo ...

From Alzheimer's prevention to weight-loss dominance, Novo bets on innovation and share repurchases amid Medicare pressure.

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

Europe’s Stoxx 600 index hit a record high for the first time since September, as investors grew optimistic that the harshest ...

The team categorized pediatric obesity treatment response, based on changes in body mass index standard deviation score, as ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

The pan-European STOXX 600 was up 0.5%, as of 0822 GMT, and trading at its highest level since Sept. 27, 2024. Heavyweight ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including ...